GlassScriptPhysician profile
Rachel E Pruitt
NPI 1992089841
$2,542.51
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,063 · 2020: $511 · 2021: $502 · 2022: $339 · 2023: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $128.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $309.93 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $239.55 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.84 | 2019-2022 | |
| Glaxosmithkline, LLC. | $181.83 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $181.42 | 2019-2021 | |
| Novo Nordisk INC | $175.20 | 2019-2022 | |
| Amarin Pharma, INC. | $117.73 | 2019-2021 | |
| Abbott Laboratories | $110.36 | 2019-2023 | Freestyle Libre 2 |
| Lilly USA, LLC | $109.84 | 2019-2023 | Emgality, Reyvow |
| Novartis Pharmaceuticals Corporation | $107.45 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $98.28 | 2019-2022 | |
| Astellas Pharma US INC | $94.69 | 2019-2022 | |
| Abbvie INC. | $93.30 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $89.26 | 2019-2023 | Spravato |
| Pfizer INC. | $83.95 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $75.24 | 2019-2023 | Injectafer |
| Esperion Therapeutics, INC. | $55.91 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $34.38 | 2019-2020 | |
| Allergan, INC. | $26.14 | 2019-2020 | |
| Philips North America LLC | $26.07 | 2020 | |
| Merck Sharp & Dohme LLC | $24.49 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $24.28 | 2019-2020 | |
| Intuity Medical INC | $24.01 | 2022 | |
| Inari Medical, INC. | $21.73 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bayer Healthcare Pharmaceuticals INC. | $16.11 | 2022 | |
| Hologic Sales and Service, LLC | $12.63 | 2019 | |
| Genentech USA, INC. | $11.56 | 2019 | |
| Ironwood Pharmaceuticals, INC | $11.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Pruitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.